Thomas Kinane, MD
Pediatric Pulmonology · Boston, MANPI 1861482770
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $60,113 of the $66,789 with a category attached, or 90.0%. 5 manufacturers reported payments, led by Sanofi-aventis U.S. LLC at 46.8% of the total. Reporting peaked in 2019 at $28,922 and has fallen 90.7% since, to $2,681 in 2025. Among pediatric pulmonology clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 47 payments — averaging $1421.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi-aventis U.S. LLC$31K
- Sarepta Therapeutics, Inc.$22K
- Sanofi US Services Inc.$13K
- Inspire Medical Systems, Inc.$332
- Genentech USA, Inc.$132
What the payments were for
- Consulting fees$60,11390%
- Speaking & faculty fees$6,2139%
- Food & beverage$4641%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi-aventis U.S. LLC | 30 | $31,290 |
| Sarepta Therapeutics, Inc. | 1 | $22,000 |
| Sanofi US Services Inc. | 12 | $13,036 |
| Inspire Medical Systems, Inc. | 2 | $332 |
| Genentech USA, Inc. | 2 | $132 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Exondys 51$22,000
- NEXVIAZYME$11,518
- GZ402666$4,968
- XENPOZYME$3,476
- NO PRODUCT DISCUSSED$788
- Inspire$332
- XOLAIR$128
How this compares
$66,789 in reported general payments places this provider in the 90th percentile of 40 pediatric pulmonology providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atrovent HfaIpratropium Bromide | 11 | $7,862 |
| Hydroxyzine Hcl | 11 | $524 |
Paid to pharmacies, not to this prescriber.
Other pediatric pulmonology in Boston
- Gregory SawickiBoston$96K
- Claudia OrdonezBoston$73K
- Ahmet UluerBoston$61K
- Lael YonkerBoston$21K
- Robyn CohenBoston$16K
- Scott SchroederBoston$9K
- Henry DorkinBoston$6K
- Gary VisnerBoston$6K
- Jonathan GaffinBoston$1K
- Thomas MartinBoston$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.